Tanaka N - Search Results

1

Predictors of the efficacy of interferon therapy in chronic hepatitis C virus infection. Tokyo-Chiba Hepatitis Research Group.

Shiratori Y, Kato N, Yokosuka O, Imazeki F, Hashimoto E, Hayashi N, Nakamura A, Asada M, Kuroda H, Tanaka N, Arakawa Y, Omata M. Shiratori Y, et al. Among authors: tanaka n. Gastroenterology. 1997 Aug;113(2):558-66. doi: 10.1053/gast.1997.v113.pm9247476. Gastroenterology. 1997. PMID: 9247476 Clinical Trial.

2

Biochemical and virological response to interferon therapy in patients with chronic hepatitis C, co-infected with hepatitis G virus.

Shibahara N, Moriyama M, Abe K, Tanaka N, Arakawa Y. Shibahara N, et al. Among authors: tanaka n. J Viral Hepat. 2000 Jan;7(1):43-50. doi: 10.1046/j.1365-2893.2000.00191.x. J Viral Hepat. 2000. PMID: 10718942

3

A prospective study of interferon therapy modified by pre-treatment viral load in cirrhotic patients. Tokyo-Chiba Hepatitis Research Group.

Shiratori Y, Moriyama M, Imazeki F, Ohkubo H, Tanaka N, Arakawa Y, Yoshida H, Yokosuka O, Shibuya A, Matsuzaki K, Hashimoto E, Hayashi N, Hirata K, Ohashi Y, Omata M. Shiratori Y, et al. Among authors: tanaka n. Liver. 2000 Jul;20(4):271-80. doi: 10.1034/j.1600-0676.2000.020004271.x. Liver. 2000. PMID: 10959805 Clinical Trial.

4

Blinded, prospective, and serial evaluation by quantitative-EEG in interferon-alpha-treated hepatitis-C.

Kamei S, Tanaka N, Mastuura M, Arakawa Y, Kojima T, Matsukawa Y, Takasu T, Moriyama M. Kamei S, et al. Among authors: tanaka n. Acta Neurol Scand. 1999 Jul;100(1):25-33. doi: 10.1111/j.1600-0404.1999.tb00720.x. Acta Neurol Scand. 1999. PMID: 10416509

5

Persistent TT virus infection does not contribute to the development of non-A to -G hepatocellular carcinoma. A case-control study of 19 patients in Japan.

Shimizu T, Moriyama M, Tanaka N, Arakawa Y. Shimizu T, et al. Among authors: tanaka n. Intervirology. 2000;43(2):80-6. doi: 10.1159/000025028. Intervirology. 2000. PMID: 10971125

6

Molecular analysis of hepatitis D virus infection in Miyako Island, a small Japanese island.

Arakawa Y, Moriyama M, Taira M, Hayashi N, Tanaka N, Okubo H, Sugitani M. Arakawa Y, et al. Among authors: tanaka n. J Viral Hepat. 2000 Sep;7(5):375-81. doi: 10.1046/j.1365-2893.2000.00244.x. J Viral Hepat. 2000. PMID: 10971826

7

Hepatitis G virus coinfection influences the liver histology of patients with chronic hepatitis C.

Moriyama M, Matsumura H, Shimizu T, Shioda A, Kaneko M, Saito H, Miyazawa K, Tanaka N, Sugitani M, Komiyama K, Arakawa Y. Moriyama M, et al. Among authors: tanaka n. Liver. 2000 Oct;20(5):397-404. doi: 10.1034/j.1600-0676.2000.020005397.x. Liver. 2000. PMID: 11092258

8

Serum concentration of interferon-alpha: a comparison between once-a-day and twice-a-day administration.

Matsukawa Y, Nishinarita S, Horie T, Moriyama M, Tanaka N, Arakawa Y, Kamei S, Matsuura M, Kojima T. Matsukawa Y, et al. Among authors: tanaka n. Int J Clin Pharmacol Res. 2000;20(1-2):17-9. Int J Clin Pharmacol Res. 2000. PMID: 11146898 Clinical Trial.

9

Detection of serum and intrahepatic human hepatocyte growth factor in patients with type C liver diseases.

Yamagami H, Moriyama M, Tanaka N, Arakawa Y. Yamagami H, et al. Among authors: tanaka n. Intervirology. 2001;44(1):36-42. doi: 10.1159/000050028. Intervirology. 2001. PMID: 11223718

10

Histopathologic impact of TT virus infection on the liver of type C chronic hepatitis and liver cirrhosis in Japan.

Moriyama M, Matsumura H, Shimizu T, Shioda A, Kaneko M, Miyazawa K, Miyata H, Tanaka N, Uchida T, Arakawa Y. Moriyama M, et al. Among authors: tanaka n. J Med Virol. 2001 May;64(1):74-81. doi: 10.1002/jmv.1020. J Med Virol. 2001. PMID: 11285572

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,540 results

Search Page

Filters